EarlySight logo — See the invisible

EarlySight

See the invisible

Founded 2019 Switzerland Geneva, Switzerland 10 employees Seed Total: $2.81M Health Care

General Information

Company Name EarlySight
Founded Year 2019
Location Switzerland Geneva, Switzerland +1
Employees 10
Industries Health Care
Funding Stage Seed
Social

Get notified when EarlySight moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About EarlySight

EarlySight, founded in 2019 and headquartered in Switzerland, has recently secured a noteworthy €2.70M Seed Round investment on 26 May 2021 from Verve Ventures and Nina Ventures. The startup's vision is to "See the invisible," aiming to combat vision loss by enhancing the detection and monitoring of eye diseases. EarlySight's breakthrough lies in the development of a high-performance eye imaging instrument that enables ophthalmologists to visualize the morphology of previously invisible cells in the retina, which play critical roles in degenerative eye diseases. The company's technology is poised to significantly enhance the detection and monitoring of various conditions like age-related macular degeneration. It promises to provide quantitative evidence of treatment efficacy and accelerate the development of new therapies. Furthermore, EarlySight's innovative approach allows for non-invasive assessment of retinal health and swift monitoring of treatment effects, eliminating the need to wait for months to observe changes in visual acuity. Overall, EarlySight's recent funding injection and pioneering approach in leveraging technology to revolutionize ophthalmic care demonstrate its potential to make substantial strides in addressing and combating vision-related health issues within the Health Care industry.

Taxonomy: ophthalmology, vision, eye imaging, retina health, disease detection, treatment monitoring, innovation, clinical development, ophthalmic instruments, disease monitoring, age-related macular degeneration, treatment efficacy, therapies

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 2
Investor Investor
26 May 2021
Non Equity Assistance •••••• 1
Investor
21 Oct 2020
Pre Seed Round •••••• 1
Investor
30 Aug 2020
Grant •••••• 1
Investor
10 Mar 2020
Debt Financing •••••• 1 •••• •••• 28 Feb 2020

EarlySight Alternatives & Competitors

EarlySight vs

Multi-specialty ophthalmology practice in Doylestown, PA, Hopewell and Hamilton, NJ | Affiliate of P...

30 employees
Health Care
EarlySight vs
JuneBrain Inc.
JuneBrain Inc. United States

Empowering eye care and neurology communities through remote monitoring of disease.

Non Equity Assistance
13 employees
Biotechnology, Health Care
EarlySight vs

Reach For Healthy Eyes

Private Equity
41 employees
Fashion, Health Care

FAQ About EarlySight

See the invisible
EarlySight was founded in 2019.
EarlySight is headquartered in Geneva, Switzerland.
EarlySight operates in the following industries: Health Care.
EarlySight has approximately 10 employees.
EarlySight has completed 5 funding rounds, raising a total of $2.81M. The latest funding stage is Seed.
Top alternatives and competitors to EarlySight include Matossian Eye Associates, JuneBrain Inc., American Eye Associates, LLC, Sherpa, Smartlens. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
EarlySight and Matossian Eye Associates are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors EarlySight and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy